Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Aug 26;12(17):5573.
doi: 10.3390/jcm12175573.

Sarcopenia Adversely Affects Outcomes following Cardiac Surgery: A Systematic Review and Meta-Analysis

Affiliations
Review

Sarcopenia Adversely Affects Outcomes following Cardiac Surgery: A Systematic Review and Meta-Analysis

Ali Ansaripour et al. J Clin Med. .

Abstract

Background: Sarcopenia is a degenerative condition characterised by the loss of skeletal muscle mass and strength. Its impact on cardiac surgery outcomes remains poorly investigated. This meta-analysis aims to provide a comprehensive synthesis of the available evidence to determine the effect of sarcopenia on cardiac surgery outcomes.

Methods: A systematic review and meta-analysis followed PRISMA guidelines from inception to April 2023 in EMBASE, MEDLINE, Cochrane database, and Google Scholar. Twelve studies involving 2717 patients undergoing cardiac surgery were included. Primary outcomes were early and late mortality; secondary outcomes included surgical time, infection rates, and functional outcomes. Statistical analyses were performed using appropriate methods.

Results: Sarcopenic patients (906 patients) had a significantly higher risk of early mortality (OR: 2.40, 95% CI: 1.44 to 3.99, p = 0.0007) and late mortality (OR: 2.65, 95% CI: 1.57 to 4.48, p = 0.0003) compared to non-sarcopenic patients (1811 patients). There were no significant differences in overall surgical time or infection rates. However, sarcopenic patients had longer ICU stays, higher rates of renal dialysis, care home discharge, and longer intubation times.

Conclusion: Sarcopenia significantly increases the risk of early and late mortality following cardiac surgery, and sarcopenic patients also experience poorer functional outcomes.

Keywords: cardiac surgery; frailty; sarcopenia.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
PRISMA Flow Chart.
Figure 2
Figure 2
Forest Plots for the primary outcomes. (A) Early Mortality; (B) Late Mortality. References [12,13,14,17,18,19,20,21,22,23].
Figure 3
Figure 3
Forest Plots for the secondary outcomes focused on timing. (A) Overall surgical time; (B) CBP time; (C) CC time; (D) Hospital LOS; (E) ICU LOS; (F) Intubation time. References [12,13,14,15,16,17,18,20,21,22,23].
Figure 4
Figure 4
Forest Plots for the secondary outcomes. (A) Postoperative arrhythmia; (B) Stroke; (C) Sternal wound infection; (D) Need for dialysis; (E) discharge to care home; (F) Sensitivity analysis: Hospital LOS. References [12,13,14,15,16,17,18,20,21,22,23].

References

    1. Cruz-Jentoft A.J., Bahat G., Bauer J., Boirie Y., Bruyère O., Cederholm T., Cooper C., Landi F., Rolland Y., Sayer A.A., et al. Sarcopenia: Revised European consensus on definition and diagnosis. Age Ageing. 2019;48:16–31. doi: 10.1093/ageing/afy169. - DOI - PMC - PubMed
    1. Xia L., Zhao R., Wan Q., Wu Y., Zhou Y., Wang Y., Cui Y., Shen X., Wu X. Sarcopenia and adverse health-related outcomes: An umbrella review of meta-analyses of observational studies. Cancer Med. 2020;9:7964–7978. doi: 10.1002/cam4.3428. - DOI - PMC - PubMed
    1. He N., Zhang Y., Zhang L., Zhang S., Ye H. Relationship Between Sarcopenia and Cardiovascular Diseases in the Elderly: An Overview. Front. Cardiovasc. Med. 2021;8:743710. doi: 10.3389/fcvm.2021.743710. - DOI - PMC - PubMed
    1. Pring E.T., Gould L.E., Malietzis G., Lung P., Bharal M., Fadodun T., Bassett P., Naghibi M., Taylor C., Drami I., et al. BiCyCLE NMES—Neuromuscular electrical stimulation in the perioperative treatment of sarcopenia and myosteatosis in advanced rectal cancer patients: Design and methodology of a phase II randomised controlled trial. Trials. 2021;22:621. doi: 10.1186/s13063-021-05573-2. - DOI - PMC - PubMed
    1. Cruz-Jentoft A.J., Baeyens J.P., Bauer J.M., Boirie Y., Cederholm T., Landi F., Martin F.C., Michel J.-P., Rolland Y., Schneider S.M., et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39:412–423. doi: 10.1093/ageing/afq034. - DOI - PMC - PubMed

LinkOut - more resources